120 related articles for article (PubMed ID: 2548699)
1. The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma.
Daibata M; Kubonishi I; Eguchi T; Yano S; Ohtsuki Y; Miyoshi I
Cancer; 1989 Sep; 64(6):1248-53. PubMed ID: 2548699
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a new Epstein-Barr virus nuclear antigen-positive B-cell line, BALL-2, with t(8;14) (q24;q32) chromosome abnormality from B-cell acute lymphoblastic leukemia, L2.
Kubonishi I; Daibata M; Yano S; Isobe M; Kurosawa N; Nagumo H; Ogita Z; Ohyashiki JH; Toyama K; Miyoshi I
Am J Hematol; 1991 Jul; 37(3):179-85. PubMed ID: 1650133
[TBL] [Abstract][Full Text] [Related]
3. Type-C virus-like particles in a human B-cell lymphoma cell line.
Kubonishi I; Ohtsuki Y; Sawada T; Yano S; Eguchi T; Iwahara Y; Takeuchi C; Miyoshi I
Am J Hematol; 1990 Sep; 35(1):62-4. PubMed ID: 2167609
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma cell line (FL-18) and Epstein-Barr virus-carrying cell line (FL-18-EB) obtained from a patient with follicular lymphoma: monoclonal derivation and different properties.
Doi S; Ohno H; Tatsumi E; Arita Y; Kamesaki H; Fukuhara S; Nishikori M; Miwa H; Kita K; Hatanaka M
Blood; 1987 Nov; 70(5):1619-23. PubMed ID: 2822175
[TBL] [Abstract][Full Text] [Related]
5. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a new human B cell line carrying t(11;14) chromosome abnormality.
Daibata M; Takasaki M; Hirose S; Kubonishi I; Taguchi H; Ohtsuki Y; Miyoshi I
Jpn J Cancer Res; 1987 Nov; 78(11):1182-5. PubMed ID: 3121553
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
[TBL] [Abstract][Full Text] [Related]
8. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
[TBL] [Abstract][Full Text] [Related]
9. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
10. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
Sculley TB; Spelsberg TC; Pearson GR
Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
[TBL] [Abstract][Full Text] [Related]
12. Burkitt-like lymphoma in an English child: characterisation of tumour biopsy cells and of the derived tumour cell line.
Finerty S; Rowe M; Berry PJ; Ranson DL; Mott MG; Gregory CD; Rickinson AB
Br J Cancer; 1986 Sep; 54(3):385-91. PubMed ID: 3019376
[TBL] [Abstract][Full Text] [Related]
13. Infection of leukaemic B lymphocytes by Epstein Barr virus.
Doyle MG; Catovsky D; Crawford DH
Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
[TBL] [Abstract][Full Text] [Related]
14. Catalogue of Epstein-Barr virus (EBV) receptors on human malignant and non-malignant hematopoietic cell lines.
Tatsumi E; Harada S; Kuszynski C; Volsky D; Minowada J; Purtilo DT
Leuk Res; 1985; 9(2):231-8. PubMed ID: 2985880
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of an Epstein-Barr virus nuclear antigen-negative hairy cell line.
Lang AB; Odermatt BF; Gut DR; Rüttner JR
Exp Cell Biol; 1985; 53(2):61-8. PubMed ID: 2984056
[TBL] [Abstract][Full Text] [Related]
16. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
Sample J; Brooks L; Sample C; Young L; Rowe M; Gregory C; Rickinson A; Kieff E
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6343-7. PubMed ID: 1648738
[TBL] [Abstract][Full Text] [Related]
17. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia.
Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE
Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777
[TBL] [Abstract][Full Text] [Related]
18. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and human chromosomes: close association of the resident viral genome and the expression of the virus-determined nuclear antigen (EBNA) with the presence of chromosome 14 in human-mouse hybrid cells.
Yamamoto K; Mizuno F; Matsuo T; Tanaka A; Nonoyama M; Osato T
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5155-9. PubMed ID: 217014
[TBL] [Abstract][Full Text] [Related]
20. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
